Paper345448
The treatment of thyroid carcinoma with radioactive iodine.
Beierwaltes WH. Semin Nucl Med, 1978. Cited by 188 papers, by iCite.
Cite this record
ConductScience Library. The treatment of thyroid carcinoma with radioactive iodine. Papers, record 345448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/345448
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Iodine Radioisotopes | Major topic |
| Thyroid Neoplasms | Major topic |
| Goiter, Nodular | |
| Humans | |
| Leukemia | |
| Methods | |
| Neoplasm Metastasis | |
| Radionuclide Imaging | |
| Recurrence | |
| Thyroidectomy | |
| Thyrotropin |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 188 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942330 | The Use of Radioactive Iodine in the Treatment of Thyroid Cancer: Novel Aspects. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942330 | PubMed |
| 38672667 | Theranostic Risk Stratification for Thyroid Cancer in the Genomic Paradigm. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38672667 | PubMed |
| 36699895 | Effectiveness of mobile robots collecting vital signs and radiation dose rate for patients receiving Iodine-131 radiotherapy: A randomized clinical trial. | Front Public Health | 2022 | https://conductscience.org/library/papers/36699895 | PubMed |
| 35885666 | Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35885666 | PubMed |
| 34773164 | Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/34773164 | PubMed |
| 34745257 | Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis. | Int J Endocrinol | 2021 | https://conductscience.org/library/papers/34745257 | PubMed |
| 31772036 | Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy. | Cancer Res | 2020 | https://conductscience.org/library/papers/31772036 | PubMed |
| 28775409 | RADIOIODINE THERAPY FOR DIFFERENTIATED THYROID CARCINOMA : INHS ASVINI EXPERIENCE. | Med J Armed Forces India | 1998 | https://conductscience.org/library/papers/28775409 | PubMed |
| 27408836 | Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer. | Asia Ocean J Nucl Med Biol | 2013 | https://conductscience.org/library/papers/27408836 | PubMed |
| 25125997 | Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number? | World J Nucl Med | 2013 | https://conductscience.org/library/papers/25125997 | PubMed |
| 22589604 | Rational management of differentiated thyroid cancer. | Malays J Med Sci | 2006 | https://conductscience.org/library/papers/22589604 | PubMed |
| 21880704 | The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. | Endocr Rev | 2011 | https://conductscience.org/library/papers/21880704 | PubMed |
| 18697524 | Anniversary paper: nuclear medicine: fifty years and still counting. | Med Phys | 2008 | https://conductscience.org/library/papers/18697524 | PubMed |
| 15517490 | Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma. | World J Surg | 2004 | https://conductscience.org/library/papers/15517490 | PubMed |
| 9617595 | Drug therapy alternatives in the treatment of thyroid cancer. | Drugs | 1998 | https://conductscience.org/library/papers/9617595 | PubMed |
| 8449968 | Contributions of nuclear medicine to the therapy of malignant tumors. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8449968 | PubMed |
| 7441790 | Follicular carcinoma of the thyroid with metastasis to the breast. | J Natl Med Assoc | 1980 | https://conductscience.org/library/papers/7441790 | PubMed |
| 7233950 | Cancer of the thyroid in youth. | World J Surg | 1981 | https://conductscience.org/library/papers/7233950 | PubMed |
| 7183024 | Anaplastic carcinoma following well-differentiated thyroid cancer: etiological considerations. | Yale J Biol Med | 1982 | https://conductscience.org/library/papers/7183024 | PubMed |
| 7175109 | Comparison of serum thyroglobulin with iodine scans in thyroid cancer. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/7175109 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/345448
GET https://conductscience.org/api/papers/v1/345448/cited_by?page=2